– UK, Burton on Trent – Clinigen Group plc (LON: CLIN), the global pharmaceutical Products and Services company, today announced the appointment of Sharon Curran to its Board as a new Independent Non-Executive Director, effective from 27 April 2021.
“One area of focus for Clinigen over the past 12 months has been to bring new expertise onto the Board from industry and from other company boards. We are fortunate with Sharon that she has an equal measure of both. She has worked for multinational companies in the US and Europe, both in active executive positions as well as senior advisory on ethics and compliance, portfolio strategy and global crisis management. She has gone on to develop a broad portfolio of non-executive director roles with a variety of European companies. She is a welcome addition to the Clinigen Board and we look forward to her joining in April.” said Board Chairman, Peter Allen.
About Sharon Curran
Sharon is an experienced non-executive board director as well as having proven top-level experience in leading high-impact global marketing, commercialization, and growth strategies for world-class pharmaceutical corporations (AbbVie, Abbott Pharmaceuticals, and Eli Lilly).
She is currently a Non-Executive Director for Circassia Group plc where she is Chair of the Remuneration Committee. She is also on the Board of MorphoSys AG. Before taking these roles, she was VP, Global Marketing and Commercial Operations at AbbVie where she worked from 2012 to 2017. Whilst there, she was on the ethics & compliance committee, involved in portfolio strategy, and was part of the global crisis management team. Previously, she was Global Brand and Regional Commercial Director at Abbott Pharmaceuticals (2009-2012) and before then, she was Divisional Head, Strategy & Operations (Ireland & UK Affiliate) for Eli Lilly (1999-2008).
She has an MSc in Business Administration from Trinity College, Dublin, and a B.Sc in Biotechnology from Dublin City University. She has a Chartered Director Program Diploma from the Institute of Directors.
About Clinigen Group
Clinigen Group plc is a global, specialist pharmaceutical services and products platform focused on providing ethical access to medicines. Its mission is to deliver the right medicine to the right patient at the right time. The Group operates from sites in North America, Europe, Africa, and the Asia Pacific.
Clinigen has more than 1,250 employees across five continents in 16 countries, with supply and distribution hubs and operational centers of excellence in key long-term growth regions. The Group works with 34 of the top 50 pharmaceutical companies; interacting with over 5,000 hospitals across more than 115 countries.
For more information: https://www.clinigengroup.com
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
